Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/23258160-20170130-02 | DOI Listing |
Publication Analysis
Top Keywords
overview fovista
4
fovista rinucumab
4
rinucumab trials
4
trials fate
4
fate anti-pdgf
4
anti-pdgf medications
4
overview
1
rinucumab
1
trials
1
fate
1
Similar Publications
An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications.
Ophthalmic Surg Lasers Imaging Retina
February 2017
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.
Expert Opin Investig Drugs
February 2015
University of Central Florida, College of Medicine, 6850 Lake Nona Blvd. Orlando, FL 32827 , USA.
Introduction: The clinical development of anti-VEGF therapies for the treatment of exudative age-related macular degeneration (wet AMD) has revolutionized ophthalmology. Indeed, it has provided clinicians and patients with treatments that lessen visual loss from in a disease that once was uniformly blinding. Although blindness is yet to be eradicated from AMD, repeated intraocular anti-VEGF injections are required to preserve a patient's vision.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!